MYCN and neuroblastoma: Felipe et al. reported that the nucleosome remodeling factor BPTF interacts with N-Myc/CRC and colocalizes with the promoters of cell cycle genes, suggesting that BPTF is a potential therapeutic target for MNA-NB (Felipe et al., 2024).